Jagsonpal Pharmaceuticals
JAGSNPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: R P S Kochhar · MD: R P S Kochhar · Listing date: Sept. 12, 1996 · New Delhi · http://www.jagsonpal.com

Stock Price vs Company Growth
1d
3.3%
1w
8.4%
1m
6.4%
3m
10.5%
6m
15.4%
1y
2.0%
5y
70.8%
10y
37.9%
all
19.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 331 3.3%
270
373
Company Overview

Sales
221 Cr
Growth: 1.9%
Profit after Tax
24.5 Cr
Growth: -13.5%
Small Cap
876 Cr
P/E: 35.8x
Industry P/E: 34.6x
Fundamentals

Sales (Cr) ₹ 221
Growth 1.9%
EBITDA 11.7%
P/S 4.0x
Dividend 1.1%
P/E 35.8x
Book Value ₹ 67.3
PEG Ratio 19.8x
ROE 14.5%
P/B 5.1x
Shareholding Pattern

Institutions
Promoters
Aresko Progressive Private Limited
65.71 %
Rajpal Singh Kochhar
4.63 %
Others
Investor Education And Protection Fund Authority
1.56 %
Sanjiv Kumar Dudeja
1.41 %
Lincoln P Coelho
1.16 %
Increase    Decrease    No change
Company Profile Detailed

In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.
Investors (21)